Integrative analysis of cell death- and senescence-associated transcriptional programs identifies molecular subtypes and key genes in clear cell renal cell carcinoma

Clear cell renal cell carcinoma (ccRCC) exhibits substantial molecular and immune heterogeneity, yet the role of integrated cell death- and senescence-associated (CDS) programs remains incompletely understood. We characterized 21 CDS transcriptional signatures using multicohort transcriptomic, clinical, pharmacogenomic, and single-cell data. Consensus clustering of 538 TCGA-KIRC tumors identified three subtypes characterized by metabolic–proliferative, immune–inflammatory, and hypoxia–angiogenesis-associated profiles. The immune-enriched C2 subtype showed the poorest survival with elevated exhausted and regulatory T-cell signatures. Focusing on C2, edge perturbation analysis identified 246 network-associated genes, which were narrowed to 23 CDS-related candidates and 12 survival-associated genes. Among 101 machine-learning combinations, CoxBoost followed by random survival forest achieved the best performance, generating a ten-gene prognostic signature with a mean C-index of 0.733 across five cohorts. The resulting risk score was associated with survival outcomes and adverse clinicopathological characteristics. Among the ten genes, LMNB1, LY96, and HSPA8 were further investigated based on their differential expression and high tumor–normal discrimination AUCs. Single-cell profiling and virtual knockout analyses linked LMNB1 to T-cell cytotoxicity-associated networks, LY96 to macrophage antigen-presentation programs, and HSPA8 to T-cell cytokine signaling. Pharmacogenomic analysis identified nine compounds with differential predicted drug responses in C2. Across three independent treatment cohorts, C2 consistently exhibited the lowest response rates. Collectively, these findings demonstrate that integrated CDS transcriptional profiling delineates prognostically distinct molecular states in ccRCC, revealing an immune-enriched yet unfavorable subtype and identifying candidate genes that link cellular stress-associated programs to tumor immune heterogeneity.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-18
DOI
https://doi.org/10.21203/rs.3.rs-11446663/v1
Primary Topic
Renal cell carcinoma treatment
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Integrative analysis of cell death- and senescence-associated transcriptional programs identifies molecular subtypes and key genes in clear cell renal cell carcinoma

Xiangyi Wang, Kaihong Wang, Hao Hu
4 links
Research Square
Renal cell carcinoma treatment
preprint

Integrative analysis of cell death- and senescence-associated transcriptional programs identifies molecular subtypes and key genes in clear cell renal cell carcinoma

Xiangyi Wang, Kaihong Wang, Hao Hu
preprint en

Abstract

Clear cell renal cell carcinoma (ccRCC) exhibits substantial molecular and immune heterogeneity, yet the role of integrated cell death- and senescence-associated (CDS) programs remains incompletely understood. We characterized 21 CDS transcriptional signatures using multicohort transcriptomic, clinical, pharmacogenomic, and single-cell data. Consensus clustering of 538 TCGA-KIRC tumors identified three subtypes characterized by metabolic–proliferative, immune–inflammatory, and hypoxia–angiogenesis-associated profiles. The immune-enriched C2 subtype showed the poorest survival with elevated exhausted and regulatory T-cell signatures. Focusing on C2, edge perturbation analysis identified 246 network-associated genes, which were narrowed to 23 CDS-related candidates and 12 survival-associated genes. Among 101 machine-learning combinations, CoxBoost followed by random survival forest achieved the best performance, generating a ten-gene prognostic signature with a mean C-index of 0.733 across five cohorts. The resulting risk score was associated with survival outcomes and adverse clinicopathological characteristics. Among the ten genes, LMNB1, LY96, and HSPA8 were further investigated based on their differential expression and high tumor–normal discrimination AUCs. Single-cell profiling and virtual knockout analyses linked LMNB1 to T-cell cytotoxicity-associated networks, LY96 to macrophage antigen-presentation programs, and HSPA8 to T-cell cytokine signaling. Pharmacogenomic analysis identified nine compounds with differential predicted drug responses in C2. Across three independent treatment cohorts, C2 consistently exhibited the lowest response rates. Collectively, these findings demonstrate that integrated CDS transcriptional profiling delineates prognostically distinct molecular states in ccRCC, revealing an immune-enriched yet unfavorable subtype and identifying candidate genes that link cellular stress-associated programs to tumor immune heterogeneity.

Research Square
Nanchang University (CN), Chongqing Medical University (CN)
Good health and well-being
Renal cell carcinoma treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon